Dual-targeting pro-apoptotic peptide for programmed cancer cell death via specific mitochondria damage

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Chen, Wei Hai ^a   Xu, Xiao Ding ^a   Luo, Guo Feng ^a   Jia, Hui Zhen ^a   Lei, Qi ^a   Cheng, Si Xue ^a   Zhuo, Ren Xi ^a   Zhang, Xian Zheng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL SURVIVAL; DRUG EFFECTS; ENDOCYTOSIS; HELA CELL LINE; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEOPLASM; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; ENDOCYTOSIS; HELA CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; PEPTIDES;

EID: 84890756644     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03468     Document Type: Article

References (41)

1. Szewczyk, A. & Wojtczak, L. Mitochondria as a pharmacological target. Pharmacol. Rev. 54, 101-127 (2002). (Pubitemid 34211027)
2. Pathania, D., Millard, M. & Neamati, N. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev. 61, 1250-1275 (2009).
3. Green, D. R. & Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626-629 (2004). (Pubitemid 39006738)
4. Wen, S., Zhu, D. & Huang, P. Targeting cancer cell mitochondria as a therapeutic approach. Future Med. Chem. 5, 53-67 (2013).
5. Biasutto, L., Dong, L. F., Zoratti, M. & Neuzil, J. Mitochondrially targeted anticancer agents. Mitochondrion 10, 670-681 (2010).
6. Chen, W. H. et al. A new anti-cancer strategy of damaging mitochondria by proapoptotic peptide functionalized gold nanoparticles. Chem. Commun. 49, 6403-6405 (2013).
7. Yamada, Y., Akita, H., Kogure, K., Kamiya, H. & Harashima, H. Mitochondrial drug delivery and mitochondrial disease therapy-an approach to liposomebased delivery targeted to mitochondria. Mitochondrion 7, 63-71 (2007). (Pubitemid 46351977)
8. Costantini, P., Jacotot, E., Decaudin, D. & Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92, 1042-1053 (2000). (Pubitemid 30616479)
9. Spierings, D. et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310, 66-67 (2005). (Pubitemid 41434533)
10. Ellerby, H. M. et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5, 1032-1038 (1999). (Pubitemid 29439574)
11. Agemy, L. et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc. Natl. Acad. Sci. U. S. A. 108, 17450-17455 (2011).
12. Mohanty, C., Das, M., Kanwar, J. R. & Sahoo, S. K. Receptor mediated tumor targeting: an emerging approach for cancer therapy. Curr. Drug Deliv. 8, 45-58 (2011).
13. Fan, N. C., Cheng, F. Y., Ho, J. A. & Yeh, C. S. Photocontrolled targeted drug delivery: photocaged biologically active folic acid as a light-responsive tumortargeting molecule. Angew. Chem. Int. Ed. 51, 8806-8810 (2012).
14. Rajendran, L., Knölker, H. J. & Simons, K. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29-42 (2010).
15. Xu, P., Van Kirk, E. A., Zhan, Y., Murdoch, W. J., Radosz, M. & Shen, Y. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew. Chem. Int. Ed. 46, 4999-5002 (2007). (Pubitemid 47055979)
16. Pan, L., He, Q., Liu, J., Chen, Y.,Ma, M., Zhang, L. & Shi, J. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 134, 5722-5725 (2012).
17. Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129 (2008).
18. Smith, R. A., Porteous, C. M., Gane, A. M. & Murphy, M. P. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. U. S. A. 100, 5407-5412 (2003). (Pubitemid 36542718)
19. Robinson, K. M. et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. U. S. A. 103, 15038-15043 (2006). (Pubitemid 44583160)
20. Bessalle, R., Kapitkovsky, A., Gorea, A., Shalit, I. & Fridkin, M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274, 151-155 (1990). (Pubitemid 20378143)
21. Javadpour, M. M. et al. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 39, 3107-3113 (1996). (Pubitemid 26260315)
22. Legigan, T. et al. The first generation of b-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. Angew. Chem. Int. Ed. 51, 11606-11610 (2012).
23. Wagner, B. K. et al. Large-scale chemical dissection of mitochondrial function. Nat. Biotechnol. 26, 343-351 (2008). (Pubitemid 351355127)
24. Smiley, S. T. et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. U. S. A. 88, 3671-3675 (1991). (Pubitemid 21916685)
25. Perry, S. W., Norman, J. P., Barbieri, J., Brown, E. B. & Gelbard, H. A. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50, 98-115 (2011).
26. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309-1312 (1998). (Pubitemid 28406816)
27. Xia, T., Jiang, C., Li, L., Wu, C., Chen, Q. & Liu, S. S. A study on permeability transition pore opening and cytochrome c release from mitochondria, induced by caspase-3 in vitro. FEBS Lett. 510, 62-66 (2002). (Pubitemid 34084885)
28. Lakhani, S. A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847-851 (2006). (Pubitemid 43228848)
29. Kroemer, G., Galluzzi, L. & Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163 (2007). (Pubitemid 46209992)
30. Levine, B. & Yuan, J. Autophagy in cell death: an innocent convict? J. Clin. Invest. 115, 2679-2688 (2005). (Pubitemid 41434392)
31. Kroemer, G.&Levine, B. Autophagic cell death: the story of amisnomer. Nat. Rev. Mol. Cell Biol. 9, 1004-1010 (2008).
32. Kim, I., Rodriguez-Enriquez, S. & Lemasters, J. J. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462, 245-253 (2007). (Pubitemid 46876640)
33. Tolkovsky, A. M., Xue, L., Fletcher, G. C. & Borutaite, V. Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? Biochimie 84, 233-240 (2002).
34. Andón, F. T. & Fadeel, B. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. 46, 733-742 (2013).
35. Shao, Y., Gao, Z., Marks, P. A. & Jiang, X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101, 18030-18035 (2004). (Pubitemid 40054069)
36. Xue, L., Fletcher, G. C. & Tolkovsky, A. M. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell Neurosci. 14, 180-198 (1999). (Pubitemid 29449222)
37. Gozuacik, D. & Kimchi, A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23, 2891-2906 (2004). (Pubitemid 38638851)
38. Pattingre, S. et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 122, 927-939 (2005). (Pubitemid 41345209)
39. Pattingre, S. & Levine, B. Bcl-2 inhibition of autophagy: a new route to cancer? Cancer Res. 66, 2885-2888 (2006).
40. Gershell, L. J. & Atkins, J. H. A brief history of novel drug discovery technologies. Nat. Rev. Drug Discov. 2, 321-327 (2003). (Pubitemid 37361690)
41. Pereira, M. P. & Kelley, S. O. Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells. J. Am. Chem. Soc. 133, 3260-3263 (2011).